Colgate-Palmolive Co. (NYSE:CL) belonging to the Consumer Staples sector has declined -0.01% and closed its last trading session at $67.71.
The company reported its EPS on 01/27/2017. Currently, the stock has a 1 Year Price Target of $69.69.
The consensus recommendation, according to Zacks Investment research, is 2.79. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 2.8 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.8 and 2.79 respectively.
Colgate-Palmolive Co. on 01/27/2017 reported its EPS as $0.75 with the analysts projecting the EPS of the stock as $0.75. The company beat the analyst EPS Estimate with the difference of $0. This shows a surprise factor of 0%.
Many analysts have provided their estimated foresights on Colgate-Palmolive Co. Earnings, with 16 analysts believing the company would generate an Average Estimate of $0.66. Whereas they predicted High and Low Earnings Estimate as $0.68 and $0.64 respectively. While in the same Quarter Previous year, the Actual EPS was $0.63.
Analysts are also projecting an Average Revenue Estimate for Colgate-Palmolive Co. as $3.79 Billion in the Current Quarter. This estimate is provided by 13 analysts. The High Revenue estimate is predicted as 3.86 Billion, while the Low Revenue Estimate prediction stands at 3.71 Billion. The company’s last year sales total was 3.76 Billion.
For the Current Quarter, the growth estimate for Colgate-Palmolive Co. is 4.8%, while for the Next Quarter the stock growth estimate is 2.9%. In the past 5 years, the stock showed growth of 1.65% per annum. While for the next 5 years, the growth estimate is 8.73%.
The Company got Downgrade by Citigroup on 30-Jan-17 from Buy to Neutral.
Insider Trades for Colgate-Palmolive Co. show that the latest trade was made on 2 Feb 2017 where Sadove (Stephen I), the Director completed a transaction type “Sell” in which 8000 shares were traded at a price of $66.
25 Insider Sales transactions were made totaling 452150 shares traded.
16 analysts projected Price Targets for Colgate-Palmolive Co.. The analysts believe that the company stock price could grow as high as $77. The Low Price target projection by analysts is $63 and the Mean Price Target is $69.69.
Colgate-Palmolive Co. (NYSE:CL) has the market capitalization of $60.11 Billion. The company rocked its 52-Week High of $75.38 on Aug 12, 2016 and touched its 52-Week Low of $63.43 on Jan 27, 2017. The stock has Return on Assets (ROA) of 19.6 percent. Return on Equity (ROE) stands at -950.7% and Return on Investment (ROI) of 42.7 percent.
The stock is currently showing YTD performance of 4.07 Percent. The company has Beta Value of 0.71 and ATR value of 0.94. The Weekly and Monthly Volatility stands at 1.25% and 1.23%.
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Household Surface Care, Fabric Care and Pet Nutrition. Colgate sells its products in countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Ajax, Axion, Soupline, Suavitel and Fab, as well as Hill’s Science Diet and Hill’s Prescription Diet pet foods. (Company Press Release)